TY - JOUR
T1 - Novel mutations, no detectable mRNA and familial genetic analysis of the Wiskott-Aldrich syndrome protein gene in six Japanese patients with Wiskott- Aldrich syndrome
AU - Sasahara, Y.
AU - Kawai, S.
AU - Kumaki, S.
AU - Ohashi, Y.
AU - Minegishi, M.
AU - Tsuchiya, S.
PY - 2000
Y1 - 2000
N2 - The Wiskott-Aldrich syndrome (WAS) is a primary X-linked immunodeficiency disease caused by mutations of the Wiskott-Aldrich syndrome protein (WASP) gene. The present molecular studies of six Japanese was patients identified five different mutations of WASP, including two novel mutations (45delG, 395insGGAGAT), the latter appearing to have occurred de novo. Familial carriers were detected by polymerase chain reaction-single strand conformational polymorphism analysis, restriction enzyme digestion and direct sequencing of PCR products. Neither mRNA nor the protein product were detectable in any of the patients, while various amounts of WASP protein were expressed in carriers, normal controls, haematopoietic cell lines of all lineages and in one patient after receiving allogeneic bone marrow transplantation. Conclusion: Genetic and protein analysis is useful in the definite diagnosis and follow up of Wiskott-Aldrich syndrome patients and in carrier detection, especially of atypical or sporadic patients.
AB - The Wiskott-Aldrich syndrome (WAS) is a primary X-linked immunodeficiency disease caused by mutations of the Wiskott-Aldrich syndrome protein (WASP) gene. The present molecular studies of six Japanese was patients identified five different mutations of WASP, including two novel mutations (45delG, 395insGGAGAT), the latter appearing to have occurred de novo. Familial carriers were detected by polymerase chain reaction-single strand conformational polymorphism analysis, restriction enzyme digestion and direct sequencing of PCR products. Neither mRNA nor the protein product were detectable in any of the patients, while various amounts of WASP protein were expressed in carriers, normal controls, haematopoietic cell lines of all lineages and in one patient after receiving allogeneic bone marrow transplantation. Conclusion: Genetic and protein analysis is useful in the definite diagnosis and follow up of Wiskott-Aldrich syndrome patients and in carrier detection, especially of atypical or sporadic patients.
KW - Mutations Carriers Bone marrow transplantation
KW - Wiskott-Aldrich syndrome
KW - Wiskott-Aldrich syndrome protein
UR - http://www.scopus.com/inward/record.url?scp=0033999642&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033999642&partnerID=8YFLogxK
U2 - 10.1007/s004310050005
DO - 10.1007/s004310050005
M3 - Article
C2 - 10653325
AN - SCOPUS:0033999642
SN - 0340-6199
VL - 159
SP - 23
EP - 30
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
IS - 1-2
ER -